Hee-Young Yang

Hee-Young Yang

Auto-generated profile, based on publicly available information

Hee-Young Yang

Preclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Oncology Research
Verified
Journal Article
Open access
LRLina Ren
Lina Ren
HYHee-Young Yang
Hee-Young Yang
HCHoon-In Choi
Hoon-In Choi
KCKyoung-Jin Chung
Kyoung-Jin Chung
UYUng Yang
Ung Yang
TLTae Hoon Lee
Tae Hoon Lee
(−)-Epigallocatechin 3-gallate (EGCG) is a potent antioxidant polyphenol in green tea that acts as an anticancer agent via both direct and indirect pathways. Although the relationship between EGCG's anticancer effects and its antioxidant activity is not fully understood, it is known that EGCG stimulates production of reactive oxygen species (ROS), which induce oxidative stress leading to cell death. In IM9 multiple myeloma cells, EGCG acted in a dose- and time-dependent manner to induce apoptotic cell death. Among the antioxidant enzymes expressed in IM9 cells, levels of peroxiredoxin V (PrdxV) were selectively and significantly reduced by EGCG. Moreover, the ROS scavenger NAC completely inhibited EGCG-induced apoptosis and PrdxV reduction, while overexpression of PrdxV, but not a PrdxVC48S mutant, protected IM9 cells from EGCG-induced apoptosis. EGCG-induced reductions in cell viability and PrdxV levels were also observed in primary CD138+ multiple myeloma cells from patients. These results suggest that PrdxV is a key target via which EGCG mediates its anticancer effects.

29 August 2016 in Redox Report
Verified
Journal Article
Open access
SKSuhee Kim
Suhee Kim
SASun Hee Ahn
Sun Hee Ahn
HYHee-Young Yang
Hee-Young Yang
JLJin-Sil Lee
Jin-Sil Lee
HCHyang-Gi Choi
Hyang-Gi Choi
TLTae Hoon Lee
Tae Hoon Lee
Objectives: In tissue samples from patients with colorectal cancer (CRC), oxidation of C420 and C457 of plakoglobin (Pg) within tumor tissue was identified by proteomic analysis. The aim of this study was to identify the roles of Pg C420 and C457. Methods: Human CRC tissues, CRC and breast cancer cells, and normal mouse colon were prepared to validate Pg oxidation. MC38 cells were co-transfected with E-cadherin plus wild type (WT) or mutant (C420S or C457S) Pg to evaluate protein interactions and cellular localization, proliferation, and migration. Results: Pg was more oxidized in stage III CRC tumor tissue than in non-tumor tissue. Similar oxidation of Pg was elicited by H2O2 treatment in normal colon and cancer cells. C457S Pg exhibited diminished binding to E-cadherin and α-catenin, and reduced the assembly of E-cadherin–α-/β-catenin complexes. Correspondingly, immunofluorescent analysis of Pg cellular localization suggested impaired binding of C457S Pg to membranes. Cell migration and proliferation were also suppressed in C457S-expressing cells. Discussion: Pg appears to be redox-sensitive in cancer, and the C457 modification may impair cell migration and proliferation by affecting its interaction with the E-cadherin/catenin axis. Our findings suggest that redox-sensitive cysteines of Pg may be the targets for CRC therapy.

30 April 2024 in Journal of the Korean Society of Food Science and Nutrition
Verified
Journal Article
Open access
PDF file
CJChul-Jong Jung
Chul-Jong Jung
YYYeong-Eun Yu
Yeong-Eun Yu
CSChang-Hyeon Shin
Chang-Hyeon Shin
HYHee-Young Yang
Hee-Young Yang
JPjoonheum park
joonheum park
Cheol-Jong Jung, Yeong-Eun Yu, Chang-Hyeon Shin, Hee-Young Yang, and Joonheum Park. Journal of the Korean Society of Food Science and Nutrition 2024;53:321-7. https://doi.org/10.3746/jkfn.2024.53.4.321